Tumour-derived chromosomal copy number changes (1p, 4q loss and 13q gain) and copy number changes of driver alterations including ERBB2 and CDK6 were detected in cfDNA of colorectal and breast cancer patients with good concordance rates when tumour tissue was available for analysis [56]. This evidence concerns the gene CDK6 and neoplasm.